tiprankstipranks
Kane Biotech Inc (TSE:KNE)
:KNE
Canadian Market
KNE
Kane Biotech
RESEARCH TOOLSreports
Want to see TSE:KNE full AI Analyst Report?

Kane Biotech (KNE) Financial Statements

2 Followers

Kane Biotech Financial Overview

Kane Biotech's market cap is currently C$6.15M. The company's EPS TTM is C$-0.0146; its P/E ratio is -2.05; Kane Biotech is scheduled to report earnings on August 27, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Dec 23Mar 23Dec 21
Income Statement
Total RevenueC$ 427.87KC$ 2.08MC$ 148.98KC$ 156.73KC$ 1.61M
Gross ProfitC$ -163.38KC$ 872.10KC$ 109.47KC$ 1.41MC$ 568.44K
Operating IncomeC$ -3.11MC$ -4.49MC$ -3.36MC$ -3.46MC$ -4.88M
EBITDAC$ -2.95MC$ -3.71MC$ -3.23MC$ -2.95MC$ -4.25M
Net IncomeC$ -2.72MC$ -3.02MC$ -5.03MC$ -3.89MC$ -4.60M
Balance Sheet
Cash & Short-Term InvestmentsC$ 901.70KC$ 358.81KC$ 749.25KC$ 1.10MC$ 1.15M
Total AssetsC$ 2.73MC$ 2.49MC$ 5.68MC$ 5.62MC$ 6.13M
Total DebtC$ 2.30MC$ 2.29MC$ 9.26MC$ 6.86MC$ 4.71M
Net DebtC$ 1.40MC$ 1.93MC$ 8.51MC$ 5.75MC$ 3.56M
Total LiabilitiesC$ 3.48MC$ 4.12MC$ 14.09MC$ 9.76MC$ 7.70M
Stockholders' EquityC$ -746.54KC$ -1.63MC$ -10.56MC$ -6.52MC$ -3.89M
Cash Flow
Free Cash FlowC$ -3.26MC$ -4.14MC$ -3.23MC$ -3.13MC$ -2.64M
Operating Cash FlowC$ -3.26MC$ -4.11MC$ -3.22MC$ -3.04MC$ -2.29M
Investing Cash FlowC$ -53.13KC$ 10.27MC$ -116.14KC$ -107.55KC$ -373.55K
Financing Cash FlowC$ 3.85MC$ -7.69MC$ 2.98MC$ 3.10MC$ 2.81M
Currency in CAD

Kane Biotech Earnings and Revenue History

Income Statement >

Kane Biotech Debt to Assets

Balance Sheet >

Kane Biotech Cash Flow

Cash Flow >

Kane Biotech Forecast EPS vs Actual EPS

Earnings >